47 phenotypes from 4 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Foxp3tm4(YFP/icre)Ayr/Foxp3+ Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn involves: 129S1/Sv * 129X1/SvJ	abnormal regulatory T cell morphology	J:205658
	abnormal regulatory T cell physiology	J:205658
Nr4a2tm1.1Pcn/Nr4a2+ Foxp3tm4(YFP/icre)Ayr/Foxp3+ involves: 129S1/Sv * 129X1/SvJ	abnormal regulatory T cell morphology	J:205658
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Not Specified	akinesia	J:157098
	decreased dopamine level	J:157098
	decreased dopaminergic neuron number	J:157098
	normal nervous system phenotype	J:157098
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ involves: C57BL/6 * C57BL/6NTac	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Slc6a3tm1(cre)Lrsn/Slc6a3tm1(cre)Lrsn involves: 129S1/Sv * 129X1/SvJ	abnormal dopaminergic neuron morphology	J:157098
	abnormal response/metabolism to endogenous compounds	J:157098
	decreased body size	J:157098
	decreased dopamine level	J:157098
	decreased locomotor activity	J:157098
	decreased vertical activity	J:157098
	hyperactivity	J:157098
	increased serotonin level	J:157098
	increased stereotypic behavior	J:157098
	lethality at weaning, complete penetrance	J:157098
	neuron degeneration	J:157098
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn Tg(Lck-cre)1Jtak/0 Not Specified	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
	decreased regulatory T cell number	J:205658
	normal immune system phenotype	J:205658
	increased CD4-positive, alpha-beta T cell number	J:205658
	increased susceptibility to induced colitis	J:205658
	increased susceptibility to weight loss	J:205658
	increased T-helper 1 cell number	J:205658
	neonatal lethality, incomplete penetrance	J:205658
Nr4a2tm1Niko/Nr4a2tm1Niko involves: 129S4/SvJae	decreased dopamine level	J:47684
	dehydration	J:47684
	loss of dopaminergic neurons	J:47684
	neonatal lethality, complete penetrance	J:47684
	normal nervous system phenotype	J:47684
Nr4a2tm1Omc/Nr4a2+ involves: 129S7/SvEvBrd * C57BL/6	abnormal locomotor activation	J:104902
	abnormal midbrain development	J:106612
	decreased dopamine level	J:104902
	impaired coordination	J:104902
Nr4a2tm1Omc/Nr4a2tm1Omc involves: 129S7/SvEvBrd * C57BL/6	abnormal midbrain development	J:46856
	abnormal substantia nigra morphology	J:46856
	abnormal suckling behavior	J:106612
	abnormal tegmentum morphology	J:46856
	decreased dopamine level	J:46856
	decreased locomotor activity	J:106612
	decreased noradrenaline level	J:106612
	increased midbrain apoptosis	J:46856
	neonatal lethality, complete penetrance	J:46856, J:106612
Nr4a2tm1Tpe/Nr4a2+ B6.129P2-Nr4a2tm1Tpe	abnormal dopamine level	J:147544
	abnormal noradrenaline level	J:147544
	abnormal serotonin level	J:147544
	behavioral despair	J:147544
	enhanced behavioral response to addictive substance	J:147544
	enhanced behavioral response to xenobiotic	J:147544
	hyperactivity	J:147544
	impaired passive avoidance behavior	J:147544
	increased locomotor activity	J:147544
Nr4a2tm1Tpe/Nr4a2+ involves: 129P2/OlaHsd	decreased dopamine level	J:39661
Nr4a2tm1Tpe/Nr4a2tm1Tpe involves: 129P2/OlaHsd	abnormal motor capabilities/coordination/movement	J:39661
	abnormal nervous system development	J:39661
	abnormal suckling behavior	J:39661
	decreased dopamine level	J:39661
	decreased locomotor activity	J:39661
	impaired righting response	J:39661
	loss of dopaminergic neurons	J:39661
	neonatal lethality, complete penetrance	J:39661